ST8SIA6 and hepatocellular carcinoma: These findings highlight the critical role of ST8SIA6-AS1 in the molecular and functional landscape of HCC, underscoring its potential as a target for therapeutic intervention and as a biomarker for diagnosing and monitoring the progression of this malignancy.